Capricor Therapeutics Inc (CAPR) stock news · $1.62B cap
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
This CAPR news page leads with what Capricor Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for CAPR yet. We will not pad this page with generic market recap.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CAPR stock page; for the tape open the quote page.
CAPR stock news FAQ
What is CAPR's latest net income?
Latest cached Capricor Therapeutics Inc (CAPR) net income was -$105.0M. Statements: https://lician.com/financials/capr
What is CAPR's market cap?
Capricor Therapeutics Inc (CAPR) market cap is $1.62B on the latest cached fundamentals snapshot.
What kind of company is CAPR?
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Where is CAPR stock news listed?
Cached stock news for Capricor Therapeutics Inc (CAPR) is listed at https://lician.com/news/capr. Filings: https://lician.com/sec/capr
Not investment advice.